INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
12/30/2025 04:38 PM • Pomerantz LLP is investigating potential securities fraud claims against Organogenesis Holdings Inc. following the Centers for Medicare & Medicaid Services' withdrawal of Local Coverage Determinations for skin substitute grafts on December 26, 2025. The withdrawal exposes Organogenesis to increased competition from over 300 market participants. The company's stock price fell 10.14% to $5.28 per share on the news.
ORGO - The company faces a significant regulatory setback with the withdrawal of Medicare coverage determinations for its key products, exposing it to substantially increased competition from 300+ competitors. This triggered a 10.14% stock price decline and prompted a securities fraud investigation, indicating serious negative implications for the company's business prospects and investor confidence.